Dr. Leavitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-514-3432Fax+1 415-514-3433- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1988 - 1989
- University of Michigan Health SystemResidency, Internal Medicine, 1986 - 1988
- University of Michigan Health SystemInternship, Internal Medicine, 1984 - 1985
- Harvard Medical SchoolClass of 1984
Certifications & Licensure
- CA State Medical License 1989 - 2025
- MI State Medical License 1987 - 1991
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 26 citationsTwo-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.Johnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, Susan Shapiro, Sheng-Chieh Chou, Margareth C Ozelo, Gili Kenet, Flora Peyvandi, Michael Wang, Bella Madan, ...> ;The New England Journal of Medicine. 2023 Feb 23
- 1 citationsDapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.Yang Hu, Mimansa Geere, Maham Awan, Andrew D Leavitt, Laura E Brown, Hadley J Pearson, Jocelyn S Gandelman, Scott C Kogan> ;Hematology. 2022 Dec 1
- 2 citationsIncidence of Venous Thromboembolism After Hip Arthroscopy Is Low With or Without Prophylaxis but Risk Factors Include Oral Contraceptive Use, Obesity, and Malignancy.Jordan T Holler, Ryan T Halvorson, Madeleine Salesky, C Benjamin Ma, Brian T Feeley, Andrew D Leavitt, Drew A Lansdown, Alan L Zhang> ;Arthroscopy. 2023 Apr 1
- Join now to see all
Abstracts/Posters
- Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative NeoplasmsAndrew D. Leavitt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Von Willebrand Disease Minimize Menorrhagia (VWDMin) TrialAndrew D. Leavitt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patien...Andrew D. Leavitt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- UCSF Treats Man Who Developed Rare Blood Clot After Johnson and Johnson VaccineApril 30th, 2021
- Bay Area Patient Is First MAN to Get Blood Clot After J&J VaccinationApril 26th, 2021
- Bay Area Man Is Hospitalized with Rare Blood Clot After J&J VaccinationApril 26th, 2021
- Join now to see all
Grant Support
- Molecular Mechanisms Of TPO Induced MPL Signaling In MegakaryocytesNational Heart, Lung, And Blood Institute2001–2005
- Novel Systems For The Study Of MegakaryocytopoiesisNational Heart, Lung, And Blood Institute1996–2000
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: